Tumor necrosis factor-alpha potentiates RhoA-mediated monocyte transmigratory activity in vivo at a picomolar level

Arterioscler Thromb Vasc Biol. 2009 Dec;29(12):2138-45. doi: 10.1161/ATVBAHA.109.195735. Epub 2009 Sep 10.

Abstract

Objective: The serum level of tumor necrosis factor-alpha (TNF-alpha) is in the picomolar range under inflammatory conditions. We investigated whether these picomolar levels of TNF-alpha directly modulate the functional activities of circulating monocytes.

Methods and results: In THP-1 monocytes treated with TNF-alpha (1 to 100 pmol/L/30 minutes), cytosolic RhoA small GTPase rapidly translocated to the plasma membrane via functionally active ezrin/radixin/moesin (ERM) complex, a cytoskeletal linker, and subsequent actin polymerization through NF-kappaB activation. The threonine phosphorylation of ERM was accomplished by the activation of TNF receptor type I (TNFRI) and signaling pathways involving PI3K and an atypical PKC; ie, PKCzeta. The TNF-alpha-treated monocytes (10 pmol/L) displayed more potent and prolonged generation of GTP-bound RhoA in response to secondary stimulation with RhoA-activating monocyte chemoattractant protein-1 (MCP-1). Clearly, human circulating monocytes preconditioned by 10 pmol/L TNF-alpha augmented MCP-1-mediated chemotaxis and firm adhesion on VCAM-1 and ICAM-1 in vitro and ex vivo. The elevation of serum TNF-alpha (>5 pmol/L within 16 hours), which was introduced by intraperitoneal injection of mouse-specific TNF-alpha to C57/BL6 mice, enhanced the number of CD80+ monocytes transmigrating to the JE/MCP-1-injected intraperitoneal space.

Conclusions: Picomolar concentrations of TNF-alpha in the bloodstream may prime the RhoA-dependent activities of circulating monocytes to enhance recruitment to active inflammatory foci.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Transport, Active / drug effects
  • Cell Line
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Cell Movement / drug effects
  • Cell Movement / physiology
  • Chemokine CCL2 / pharmacology
  • Cytoskeletal Proteins / metabolism
  • Humans
  • In Vitro Techniques
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / physiology
  • Male
  • Membrane Proteins / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Microfilament Proteins / metabolism
  • Monocytes / drug effects*
  • Monocytes / physiology*
  • NF-kappa B / metabolism
  • Peritoneal Cavity / cytology
  • Phosphorylation
  • Receptors, Tumor Necrosis Factor, Type I / metabolism
  • Recombinant Proteins / pharmacology
  • Tumor Necrosis Factor-alpha / administration & dosage
  • Tumor Necrosis Factor-alpha / pharmacology*
  • rho GTP-Binding Proteins / physiology*
  • rhoA GTP-Binding Protein / physiology*

Substances

  • CCL2 protein, human
  • Chemokine CCL2
  • Cytoskeletal Proteins
  • Membrane Proteins
  • Microfilament Proteins
  • NF-kappa B
  • Receptors, Tumor Necrosis Factor, Type I
  • Recombinant Proteins
  • Tumor Necrosis Factor-alpha
  • ezrin
  • RHOA protein, human
  • moesin
  • radixin
  • RhoA protein, mouse
  • rho GTP-Binding Proteins
  • rhoA GTP-Binding Protein